Fully covered metal stents versus plastic stents: The new kid on the block or the old standby?

Das, Rohit; Slivka, Adam

doi:10.1016/j.gie.2020.07.022

Cited by 3 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The advantages of FCSEMSs are the need for fewer repeat procedures and a relatively low BBS recurrence rate, but the disadvantages are their high cost and possible complications of biliary tract infection and migration [ 3 , 7 , 8 ]. Therefore, comparative studies between the two stent types continue to be conducted, and recent evidence emphasizes the benefits of using FCSEMSs for the treatment of BBS [ 9 , 10 , 11 ].…”

Section: Introductionmentioning

confidence: 99%

A Short Fully Covered Self-Expandable Metal Stent for Management of Benign Biliary Stricture Not Caused by Living-Donor Liver Transplantation

Lee,

Jang,

Chung

et al. 2024

JCM

View full text Add to dashboard Cite

Background: This study evaluated the effectiveness of short fully covered self-expanding metal stents (FCSEMS) with an anti-migration design in treating benign biliary strictures (BBS) not related to living donor liver transplantation (LDLT). Methods: A retrospective analysis was conducted on 75 patients who underwent FCSEMS insertion for BBS management. Stents were initially kept for 3 months and exchanged every 3 months until stricture resolution. Adverse events and stricture recurrence after FCSEMS removal were assessed during follow-up. Results: The study outcomes were technical success, stenosis resolution, and treatment failure. Technical success was 100%, with stricture resolution in 99% of patients. The mean onset time of BBS post-surgery was 4.4 years, with an average stent indwelling period of 5.5 months. Stricture recurrence occurred in 20% of patients, mostly approximately 18.8 months after stent removal. Early cholangitis and stent migration were noted in 3% and 4% of patients, respectively. Conclusions: This study concludes that short FCSEMS demonstrate high efficacy in the treatment of non-LDLT-related BBS, with a low incidence of interventions and complications. Although this is a single-center, retrospective study with a limited sample size, the findings provide preliminary evidence supporting the use of short FCSEMS as a primary treatment modality for BBS. To substantiate these findings, further research involving multicenter studies is recommended to provide additional validation and a broader perspective.

show abstract